Cytoprotective and genotoxic effects of vitamins K1 and B1 on irinotecan in vitro
-
Add time:07/19/2019 Source:sciencedirect.com
Cultured human lymphocytes were treated with vitamins K1 and B1, potential anticancer agents, either alone or in combination with irinotecan, a semisynthetic analogue of camptothecin. The frequency of sister chromatid exchanges (SCEs) was measured as an indicator of genotoxicity and the proliferation rate index (PRI) and mitotic index (MI) was measured as indicators of cytostatic effect. Vitamin K1 alone did not induce SCEs at the concentrations tested and combined with irinotecan does not increase SCE rates induced by irinotecan alone.Vitamin B1 significantly increased SCEs and, in combination with irinotecan, increased rates further (p < 0.05). Vitamin K1 decreased PRI and MI in combination with irinotecan, there were further increases in MI. At a low concentration, vitamin B1 reduced the levels of SCE and increased PRI induced by irinotecan. The use of these vitamins in combination with antitumor agents might reduce clinical side effects of the antineoplastics.
We also recommend Trading Suppliers and Manufacturers of Vitamin K1 (cas 11104-38-4). Pls Click Website Link as below: cas 11104-38-4 suppliers
Prev:Microalgae as a source of Vitamin K1 (cas 11104-38-4)
Next:Low Vitamin K1 (cas 11104-38-4) intake in haemodialysis patients) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Vitamin K1 (cas 11104-38-4) monitoring in pregnancies after bariatric surgery: a prospective cohort study07/26/2019
- Hypoglycemic action of Vitamin K1 (cas 11104-38-4) protects against early-onset diabetic nephropathy in streptozotocin-induced rats07/25/2019
- Intake of Vitamin K1 (cas 11104-38-4) and K2 and risk of hip fractures: The Hordaland Health Study07/24/2019
- A comparatively study of menaquinone-7 isolated from Cheonggukjang with Vitamin K1 (cas 11104-38-4) and menaquinone-4 on osteoblastic cells differentiation and mineralization07/23/2019
- Introduction of a carbon paste electrode based on nickel carbide for investigation of interaction between warfarin and Vitamin K1 (cas 11104-38-4)07/22/2019
- Development of nanoemulsions for topical delivery of Vitamin K1 (cas 11104-38-4)07/20/2019
- Low Vitamin K1 (cas 11104-38-4) intake in haemodialysis patients07/21/2019
- Microalgae as a source of Vitamin K1 (cas 11104-38-4)07/18/2019
- Quantitation of Vitamin K1 (cas 11104-38-4) in serum using online SPE-LC-MS/MS and the challenges of working with vitamin K07/17/2019
-
Health and Chemical more >


